cordycepin has been researched along with Cancer of Gallbladder in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, DF; Hu, ZM; Huang, DS; Shang, MJ; Wu, WD; Zhang, CW; Zhao, DJ | 1 |
Bao, RF; Cao, Y; Hu, YP; Jiang, L; Li, HF; Li, ML; Liu, YB; Lu, W; Mu, JS; Shu, YJ; Tan, ZJ; Wang, P; Wang, XA; Weng, H; Wu, WG; Wu, XS; Xiang, SS; Ye, YY; Zhang, F | 1 |
2 other study(ies) available for cordycepin and Cancer of Gallbladder
Article | Year |
---|---|
Cordycepin down-regulates multiple drug resistant (MDR)/HIF-1α through regulating AMPK/mTORC1 signaling in GBC-SD gallbladder cancer cells.
Topics: AMP-Activated Protein Kinases; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Deoxyadenosines; Deoxycytidine; Drug Resistance, Neoplasm; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Mechanistic Target of Rapamycin Complex 1; Multiprotein Complexes; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Cordycepin induces S phase arrest and apoptosis in human gallbladder cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Deoxyadenosines; Disease Models, Animal; Gallbladder Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Membrane Potential, Mitochondrial; Mice; Molecular Structure; Proto-Oncogene Proteins c-bcl-2; S Phase Cell Cycle Checkpoints; Tumor Burden; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2014 |